Using MRI-guided biopsies to diagnose prostate cancer with high accuracy

Many prostate cancer patients — and particularly those who don’t like the idea of prostate biopsies — think that if one uses MRI-guided biopsies alone one might only need to have one or two biopsy cores taken to accurately diagnose prostate cancer. … READ MORE …

“Extreme apical sampling” and prostate cancer diagnosis

A new article in the September issue of Prostate addresses the potential benefits of “extreme apical sampling” during the initial biopsies of men at risk for prostate cancer based on such standard parameters as PSA level, positive/negative DRE, and related factors. … READ MORE …

How many biopsy cores is the “right” number? (revised and revisited)

The current report offers a revised and updated commentary on the paper by Abd et al., first referred to yesterday on this blog. We have now had the opportunity to read the entire paper. While it does not change the general tenor of our prior comments, it is useful to make sure one has all relevant information on a topic this important. … READ MORE …

How many biopsy cores is the “right” number?

Back in the 1990s, it became customary to carry out prostate cancer biopsies under transrectal ultrasound (TRUS) guidance using the so-called “sextant” approach, under which six preplanned biopsy cores were taken from each of six specific areas of the prostate. … READ MORE …